Helius Medical Technologies, INC DEF 14A proxy statements

Solana Company announces its 2026 Annual Meeting of Stockholders, set for May 21, 2026, to elect directors and ratify auditor appointment.

Solana Company calls a special meeting to approve significant share issuances for crypto-related warrants, expand its equity incentive plan, and elect a new director amidst a strategic pivot to digital assets.

Helius Medical Technologies is calling a special meeting to vote on proposals including a reverse stock split to meet Nasdaq requirements, increasing authorized shares, and approving potential financing.

Helius Medical Technologies is asking stockholders to approve a reverse stock split and the issuance of shares upon warrant exercises to comply with Nasdaq listing requirements at its upcoming annual meeting.

Helius Medical Technologies releases a supplement to its proxy statement clarifying the quorum requirements for its upcoming Annual Meeting of Stockholders on June 27, 2024.

Helius Medical Technologies is asking stockholders to approve an amendment to its 2022 Equity Incentive Plan at the upcoming annual meeting on June 27, 2024, to increase the number of shares available for issuance and ensure continued attraction and retention of key personnel.